India may use FDA as model for bolstering its oversight

At one point, a top Indian regulator contended that India could not afford to establish the same level of expectations for its inspections of its domestic business as the U.S. did. But with FDA actions against Indian drugmakers taking a financial toll, the country is now rethinking that position. The Health Ministry and Central Drug Standards Control Organization (CDSCO), will work together on looking at the standards and guidelines of health regulators in other countries, with an emphasis on the U.S. model. FiercePharmaAsia story | More

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.